While this is decreased from ~ 70% of GFP-positive cells in Braf/Pten/Cxcr2WT tumors, is does indicate that CXCR2 positive tumor cells were present during tumor formation in both genotypes (Figure S2E). This evidence concerns the gene CXCR2 and neoplasm.